Literature DB >> 17659

Childhood pheochromocytoma: treatment with alpha methyl tyrosine for resistant hypertension.

R G Robinson, V DeQuattro, C M Grushkin, E Lieberman.   

Abstract

A 12-year-old boy with a norepinephrine-secreting pheochromocytoma that caused hypertension resistant to oral alpha adrenergic blockade is reported. Resistance to alpha adrenergic blocking agents developed when the patient's daily propranolol dosage was lowered from 10 to 1 mg/kg. Subsequently, alpha methyl tyrosine, an inhibitor of tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis, controlled the patient's blood pressure and was associated with reduction in total urinary catecholamine excretion. Norepinephrine content of the tumor and uninvolved adrenal gland removal at surgery was reduced. These findings confirm that alpha methyl tyrosine inhibited in vivo synthesis of catecholamines.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 17659     DOI: 10.1016/s0022-3476(77)80467-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  3 in total

Review 1.  The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients.

Authors:  K C Loh; P A Fitzgerald; K K Matthay; P P Yeo; D C Price
Journal:  J Endocrinol Invest       Date:  1997-12       Impact factor: 4.256

Review 2.  alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

3.  Bilateral pheochromocytomas.

Authors:  V Kalff; B Shapiro; R Lloyd; M Nakajo; J C Sisson; W H Beierwaltes
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.